Skip to main content

Table 4 Percentage of facilities with drugs in stock for HIV and malaria, by type of facility and year

From: The triple threat of pregnancy, HIV infection and malaria: reported causes of maternal mortality in two nationwide health facility assessments in Mozambique, 2007 and 2012

 

Central, Provincial & General Hospitals

Rural & District Hospitals

Health Centers & Posts

Total

2007

2012

2007

2012

2007

2012

2007

2012

 

n = 16

n = 14

n = 26

n = 41a

n = 347

n = 891

n = 389

n = 946

 

% (wt)

%

% (wt)

%

% (wt)

%

% (wt)

%

Antiretrovirals

        

 Nevirapine

71

93

74

93

23

88

26

88

 AZT

65

100

74

83

20

81

23

81

 3TC + AZT/D4T

71

na

73

na

18

na

21

na

 3TC

na

86

na

73

na

59

na

60

Antimalarials

        

Artemether + Lumefantrine (Coartem)

81

86

87

90

18

86

22

86

 Quinine (inj)

74

100

54

85

22

70

24

71

 Quinine (oral)

70

100

47

88

12

63

14

64

 Artesunate

na

29

na

5

na

7

na

7

 SP (IPTp)

94

na

83

na

32

na

35

na

  1. AZT zidovudine, 3TC lamivudine, D4T stavudine, SP sulfadoxine-pyrimethamine (Fansidar), IPTp intermittent presumptive treatment during pregnancy, na not applicable, inj injection, wt weighted
  2. a15 health centers in 2007 were reclassified as rural hospitals by 2012